Dimensional Fund Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02B | Buy |
36,422,799
+293,029
| +0.8% | +$7.8M | 0.21% | 57 |
|
|
2025
Q4 | $900M | Sell |
36,129,770
-205,761
| -0.6% | -$5.19M | 0.19% | 67 |
|
|
2025
Q3 | $925M | Buy |
36,335,531
+1,579,117
| +5% | +$39M | 0.2% | 57 |
|
|
2025
Q2 | $842M | Buy |
34,756,414
+5,430,166
| +19% | +$127M | 0.2% | 58 |
|
|
2025
Q1 | $743M | Buy |
29,326,248
+61,970
| +0.2% | +$1.62M | 0.18% | 66 |
|
|
2024
Q4 | $776M | Sell |
29,264,278
-4,126,655
| -12% | -$112M | 0.19% | 65 |
|
|
2024
Q3 | $966M | Buy |
33,390,933
+72,077
| +0.2% | +$2.1M | 0.23% | 48 |
|
|
2024
Q2 | $932M | Sell |
33,318,856
-2,370,984
| -7% | -$65.3M | 0.24% | 43 |
|
|
2024
Q1 | $990M | Sell |
35,689,840
-6,284,547
| -15% | -$174M | 0.27% | 35 |
|
|
2023
Q4 | $1.21B | Sell |
41,974,387
-3,264,945
| -7% | -$98.7M | 0.35% | 28 |
|
|
2023
Q3 | $1.5B | Sell |
45,239,332
-1,763,101
| -4% | -$62.3M | 0.49% | 15 |
|
|
2023
Q2 | $1.72B | Buy |
47,002,433
+3,357,154
| +8% | +$131M | 0.55% | 11 |
|
|
2023
Q1 | $1.78B | Buy |
43,645,279
+1,540,360
| +4% | +$66.5M | 0.6% | 9 |
|
|
2022
Q4 | $2.16M | Buy |
42,104,919
+862,505
| +2% | +$41.4M | 0.64% | 14 |
|
|
2022
Q3 | $1.8B | Buy |
41,242,414
+1,009,399
| +3% | +$49M | 0.69% | 7 |
|
|
2022
Q2 | $2.11B | Buy |
40,233,015
+1,331,272
| +3% | +$67.8M | 0.76% | 6 |
|
|
2022
Q1 | $2.01B | Sell |
38,901,743
-312,657
| -0.8% | -$16.2M | 0.62% | 7 |
|
|
2021
Q4 | $2.32B | Sell |
39,214,400
-340,280
| -0.9% | -$16.9M | 0.7% | 5 |
|
|
2021
Q3 | $1.7B | Sell |
39,554,680
-288,314
| -0.7% | -$12.8M | 0.55% | 11 |
|
|
2021
Q2 | $1.56B | Sell |
39,842,994
-19,302
| -0% | -$751K | 0.49% | 15 |
|
|
2021
Q1 | $1.44B | Sell |
39,862,296
-976,056
| -2% | -$34.7M | 0.48% | 14 |
|
|
2020
Q4 | $1.5B | Sell |
40,838,352
-3,993,052
| -9% | -$146M | 0.54% | 11 |
|
|
2020
Q3 | $1.56B | Sell |
44,831,404
-6,031,208
| -12% | -$211M | 0.66% | 10 |
|
|
2020
Q2 | $1.58B | Sell |
50,862,612
-490,492
| -1% | -$16.7M | 0.69% | 8 |
|
|
2020
Q1 | $1.59B | Buy |
51,353,104
+85,117
| +0.2% | +$2.9M | 0.83% | 8 |
|
|
2019
Q4 | $1.91B | Buy |
51,267,987
+300,176
| +0.6% | +$10.7M | 0.69% | 13 |
|
|
2019
Q3 | $1.74B | Buy |
50,967,811
+11,370
| +0% | +$413K | 0.68% | 12 |
|
|
2019
Q2 | $2.09B | Sell |
50,956,441
-2,428,104
| -5% | -$96.4M | 0.81% | 10 |
|
|
2019
Q1 | $2.15B | Sell |
53,384,545
-1,502,539
| -3% | -$60.2M | 0.86% | 8 |
|
|
2018
Q4 | $2.27B | Sell |
54,887,084
-1,329,866
| -2% | -$55.2M | 1.03% | 3 |
|
|
2018
Q3 | $2.35B | Sell |
56,216,950
-945,326
| -2% | -$36.4M | 0.89% | 8 |
|
|
2018
Q2 | $1.97B | Buy |
57,162,276
+7,440,367
| +15% | +$254M | 0.78% | 9 |
|
|
2018
Q1 | $1.67B | Buy |
49,721,909
+5,268,926
| +12% | +$181M | 0.7% | 11 |
|
|
2017
Q4 | $1.53B | Sell |
44,452,983
-908,434
| -2% | -$31M | 0.63% | 12 |
|
|
2017
Q3 | $1.54B | Sell |
45,361,417
-1,316,600
| -3% | -$42.3M | 0.67% | 9 |
|
|
2017
Q2 | $1.49B | Buy |
46,678,017
+2,137,842
| +5% | +$67.4M | 0.69% | 8 |
|
|
2017
Q1 | $1.45B | Buy |
44,540,175
+2,322,534
| +6% | +$73.2M | 0.69% | 8 |
|
|
2016
Q4 | $1.3B | Sell |
42,217,641
-546,192
| -1% | -$16.7M | 0.65% | 9 |
|
|
2016
Q3 | $1.37B | Sell |
42,763,833
-122,278
| -0.3% | -$4.09M | 0.74% | 8 |
|
|
2016
Q2 | $1.43B | Sell |
42,886,111
-2,142,431
| -5% | -$68.4M | 0.82% | 7 |
|
|
2016
Q1 | $1.27B | Sell |
45,028,542
-554,383
| -1% | -$15.8M | 0.76% | 6 |
|
|
2015
Q4 | $1.4B | Sell |
45,582,925
-1,420,849
| -3% | -$44.7M | 0.87% | 6 |
|
|
2015
Q3 | $1.4B | Sell |
47,003,774
-725,908
| -2% | -$23.3M | 0.92% | 5 |
|
|
2015
Q2 | $1.52B | Buy |
47,729,682
+4,097,884
| +9% | +$134M | 0.93% | 6 |
|
|
2015
Q1 | $1.44B | Sell |
43,631,798
-3,078,401
| -7% | -$97.9M | 0.91% | 4 |
|
|
2014
Q4 | $1.38B | Sell |
46,710,199
-359,003
| -0.8% | -$10.3M | 0.91% | 5 |
|
|
2014
Q3 | $1.32B | Buy |
47,069,202
+1,771,505
| +4% | +$49.7M | 0.94% | 5 |
|
|
2014
Q2 | $1.28B | Buy |
45,297,697
+8,514,633
| +23% | +$243M | 0.89% | 5 |
|
|
2014
Q1 | $1.12B | Buy |
36,783,064
+6,739,968
| +22% | +$201M | 0.84% | 6 |
|
|
2013
Q4 | $873M | Buy |
30,043,096
+454,260
| +2% | +$13.2M | 0.68% | 11 |
|
|
2013
Q3 | $806M | Buy |
29,588,836
+4,172,371
| +16% | +$114M | 0.7% | 9 |
|
|
2013
Q2 | $675M | Buy |
+25,416,465
| New | +$702M | 0.64% | 10 |
|
Other funds holding PFE
VCM
VPM
Dimensional Fund Advisors's PFE Position: Q1 2026 in Review
Dimensional Fund Advisors increased its Pfizer (PFE) stake by 0.81% in Q1 2026, buying an estimated $7.8M and bringing the position to 36,422,799 shares worth $1.02B. The position accounts for 0.21% of the portfolio, ranked #57.
Dimensional Fund Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.35B in Q3 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Dimensional Fund Advisors held 36,422,799 shares of Pfizer worth $1.02B as of Q1 2026.
- Dimensional Fund Advisors bought 293,029 Pfizer shares in Q1 2026, an estimated $7.8M.
- Pfizer made up 0.21% of Dimensional Fund Advisors's portfolio in Q1 2026, its #57 holding.
- Dimensional Fund Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Dimensional Fund Advisors's Pfizer position peaked at $2.35B in Q3 2018.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.